An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...
Ever-Growing USA on MSN1d
Insulin Outlet Joins the Fight for Affordable Healthcare for AllAs the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
2022 The Cigna Group Registered Shs 4.48 1.35 USD 2021 The Cigna Group Registered Shs 4.00 1.74 USD 2020 The Cigna Group Registered Shs 0.04 0.02 USD 2019 The Cigna Group Registered Shs 0.04 0.02 ...
Last year, it was clear that evolving cybersecurity trends and challenges had far-reaching impacts across all industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback